In the early days of the pandemic, with commercial COVID tests in short supply, Rockefeller University's Robert B. Darnell developed an in-house assay to identify positive cases within the Rockefeller community. It turned ...
Sep 14, 2021
1
128
As the highly transmissible delta variant of the virus that causes COVID-19 surges in the United States and around the world, rapid and accessible COVID-19 testing and increased vaccination are key to managing the virus' ...
Aug 20, 2021
0
770
Scientists at Te Herenga Waka—Victoria University of Wellington have used real-world samples to confirm the 98.7 percent accuracy of a saliva test for COVID-19. This is the first, and currently the only, COVID-19 saliva ...
Jun 28, 2021
0
3
The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain constraints. Saliva samples are easier to collect but can ...
Jun 10, 2021
0
2
International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology ...
May 28, 2021
0
5
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
May 26, 2021
0
2
To improve the development of new saliva-based diagnostic tests and personalized medicine, the National Institute of Dental and Craniofacial Research (NIDCR) has supported the development of the Human Salivary Proteome Wiki, ...
May 25, 2021
0
4
Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening.
May 20, 2021
0
5
A QUT researcher's identification of saliva as an early detection liquid biopsy for oral and throat cancer has been realized by the development and commercialisation of a diagnostic device by US-based biotech company Viome.
May 7, 2021
0
5
Scientists at the Texas A&M University Global Health Research Complex (GHRC) have identified a variant of the COVID-19 virus—"BV-1"—that could present a new challenge to public health.
Apr 20, 2021
0
55
